Genetic Factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) Are Predictor Variables for Warfarin Response in Very Elderly, Frail InpatientsÉric Pautas, Virginie Siguret, Marie‐Anne Loriot et al.|Clinical Pharmacology & Therapeutics|2009Cited by 126
Iron as a therapeutic target for Parkinson's diseaseCaroline Moreau, James A. Duce, Olivier Rascol et al.|Movement Disorders|2018Cited by 126
Diagnosis and Outcomes of Late‐Onset Wilson's Disease: A National Registry‐Based StudyChristelle Nilles, Aurélia Poujois, Mickaël Alexandre Obadia et al.|Movement Disorders|2022Cited by 26
AZP2006 in Progressive Supranuclear Palsy: A Multi-Centre, Randomized, Phase 2a Trial Assessing Safety and Biomarker OutcomesJean‐Christophe Corvol, Luc Defebvre, Mickaël Alexandre Obadia et al.|SSRN Electronic Journal|2024Cited by 0
AZP2006 in Progressive Supranuclear Palsy: A Multi-Centre, Randomized, Phase 2a Trial Assessing Safety and Biomarker OutcomesJean‐Christophe Corvol, Luc Defebvre, Mickaël Alexandre Obadia et al.|SSRN Electronic Journal|2024Cited by 0